CENTER FOR ADVANCED TECHNOLOGY
Mission
The State University of New York at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT) supports university-industry collaboration in research, education and technology transfer, with a strong focus on helping New York State-based businesses gain a technological edge on their competition. Operating under the auspices of the New York State Office of Science, Technology and Academic Research (NYSTAR), the UB CAT is fueling continued growth in some of the most promising technologies of tomorrow and in some of the most important sectors of the state's economy. The UB CAT operates within the New York State Center of Excellence in Bioinformatics & Life Sciences (CoE) under the leadership of Dr. Bruce A. Holm, Executive Director of the CoE and Senior Vice Provost at UB and Dr. Esther Takeuchi, Professor, Department of Chemical and Biological Engineering and Electrical Engineering, UB School of Engineering and Applied Sciences.
The UB CAT, one of fifteen such Centers for Advanced Technology located across the state, focuses on biomedical and bioengineering research that can lead to development of useful products with commercial potential. By accelerating science and technology transfer, the UB CAT fosters the creation of new biotech start-up companies and helps existing biomedical businesses expand through new or improved product lines. The lines of communication between translational researchers and those involved in commercialization of life sciences products and services are opened and supported through the UB CAT program on behalf of improving the health and well-being of the population and driving economic development.
Areas of Expertise
The UB CAT will consider for funding and supporting any biomedical technology or bioengineering device with application in the medical field that can improve the health and well-being of the population.
Areas of expertise for the UB CAT include:
- bioengineering
- bioimaging
- bioinformatics
- cardiovascular disease
- disease modeling
- epidemiology
- genomics
- high performance computing
- immunotherapy
- infectious disease
- neurodegenerative disease
- oncology
- ontology
- oral biology
- structural biology
- pharmacology
- proteomics
Our expertise is leveraged with a particular focus on creating products and services in the following life sciences industry sectors: biotechnology, biomedical informatics, diagnostics, medical devices, pharmaceuticals, and research & development.
Project Funding & Support
Projects are selected for CAT funding based on scientific and technical merit and potential economic impact. Additionally, projects require a cash contribution from a New York-based company. According to NYSTAR regulations, corporate sponsorship is a prerequisite for funding. Funding--up to $150,000--can be awarded to a project with matching corporate sponsor funds at a 5:1ratio (i.e. 5 corporate dollars for every NYSTAR dollar). A typical CAT grant is in the $20,000 to $50,000 range. More information on funding and matching fund guidelines is provided within the CAT application. Hand-in-hand with funding, the UB CAT also provides R&D resources and business development assistance, workforce development programming, and other outreach and networking opportunities. Visit www.bioinformatics.buffalo.edu for an updated programming and events schedule.
Application
A request for proposals has been issued for the 2008-2009 funding year. If you are a researcher or entrepreneur who needs assistance with research and development, related business development, and project funding, please download the *UB CAT Project Application. Project applications are due by May 31, 2008. Note that all projects are subject to State University of New York intellectual property policies.
Applications are reviewed on an annual basis typically for funding starting July 1st or after, although the program may at times accept submissions on a rolling basis. Projects are reviewed by the UB CAT Industrial Advisory Board in the selection process.
For more information, contact:
Marnie LaVigne, Ph.D.
UB CAT Director of Business Development
at (716) 881-8904
or lavigne2@buffalo.edu
News
Buffalo Niagara Medical Campus to Revamp Trico Site
07/19/2008 - BUFFALO, N.Y. -- Armed with a $4.5 million cash transfusion, the Buffalo Niagara Medical Campus is pushing ahead with a key physical expansion. Patrick Whelan, BNMC chief operating officer, said funding approved last week by the Empire State Development Corp. will aid a $12 million effort to turn a portion of the former Trico windshield wiper plant into a high-tech innovation center...[Read On...]
Quantum Rod System May Safely 'Sneak' Drugs, Diagnostics into Brain
07/16/2008 - BUFFALO, N.Y. --
A unique nanoparticle system developed by University at Buffalo scientists takes advantage of the versatility of bioconjugated quantum rods to ferry novel diagnostic and therapeutic agents across the blood-brain barrier, according to recent in vitro findings. Described in a paper published in Bioconjugate Chemistry, the system uses the rod-shaped semiconductor nanoparticles that are bioconjugated, or coupled, with biomolecules capable of crossing the blood-brain barrier...[Read On...]
Visit the News Archive
Events
September 23, 2008 - MedTech08 Biosciences Summit
Growing, Changing, Booming: Adapting healthcare to the needs of an aging population. Join us at The Lodge in Skaneateles NY for this exciting daylong event packed with industry leaders sharing their strategies for successfully adapting to the aging boomer demographic. To learn more and register, Click here
October 27-28, 2008 - AACR Centennial Symposium
Roswell Park Cancer Institute is hosting the American Association for Cancer Research (AACR) Centennial Symposium, entitled “The Future of Cancer Research: Science and Patient Impact”, this fall. To learn more and register, Click here.
To view the complete list of events and event details, please visit our Events page
To receive periodic News & Events emails from the COE, please join our mailing list!
